Skip to main content

Table 1 Patient and Treatment Characteristics

From: Reirradiation to the abdomen for gastrointestinal malignancies

Characteristic

Median (Range) or Number of Patients (%)

Age at Retreatment (years)

56 (37-80)

Gender

 

   Male

9 (69%)

   Female

4 (31%)

Pathology

 

   Pancreatic adenocarcinoma

3 (23%)

   Colon carcinoma

3 (23%)

   Cholangiocarcinoma

2 (15%)

   Others*

5 (38%)

Prior Radiotherapy Dose

 

   30 Gy (10-12 fractions)

2 (15%)

   35 Gy (14 fractions)

2 (15%)

   45 Gy (25 fractions)

4 (31%)

   50.4 Gy (28 fractions)

5 (38%)

Retreatment Interval (months)

26 (5-83)

Retreatment Dose**

 

   24 Gy

1 (8%)

   30 Gy

6 (46%)

   34.5 Gy

1 (8%)

   39 Gy

4 (31%)

   48 Gy

1 (8%)

Concurrent Chemotherapy

 

   Yes

8 (62%)

   No

5 (38%)

Indication for Retreatment

 

   Palliation of Pain

5 (38%)

   Palliation of Bleeding

4 (31%)

   Definitive (Not candidate for other treatments)

3 (23%)

   Consolidation after Chemotherapy

1 (8%)

  1. * Ampullary, gastric, duodenal, small bowel, and pancreatic neuroendocrine
  2. ** Retreatment was given in 1.5 Gy twice daily fractions